methane has been researched along with hematoporphyrin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, J; Hou, L; Li, L; Liu, R; Liu, Y; Ma, R; Shi, J; Wang, L; Yu, X; Zhang, J; Zhang, Z | 1 |
| Chen, Q; Ji, Y; Jiao, X; Zhang, H; Zhang, X; Zhang, Z; Zhu, X | 1 |
2 other study(ies) available for methane and hematoporphyrin
| Article | Year |
|---|---|
The application of hyaluronic acid-derivatized carbon nanotubes in hematoporphyrin monomethyl ether-based photodynamic therapy for in vivo and in vitro cancer treatment.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Drug Carriers; Hematoporphyrins; Hot Temperature; Hyaluronic Acid; Infrared Rays; Mice; Microscopy, Fluorescence; Nanotubes, Carbon; Photochemotherapy; Xenograft Model Antitumor Assays | 2013 |
A multi-functional nanoplatform for tumor synergistic phototherapy.
Topics: Animals; Drug Compounding; Drug Delivery Systems; Drug Liberation; Female; Hematoporphyrins; Humans; Hyperthermia, Induced; Injections, Subcutaneous; Lasers; MCF-7 Cells; Mice; Mice, Inbred BALB C; Molecular Targeted Therapy; Nanocomposites; Nanotubes, Carbon; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Sarcoma 180; Theranostic Nanomedicine; Titanium | 2016 |